94
Participants
Start Date
January 14, 2021
Primary Completion Date
January 19, 2023
Study Completion Date
January 19, 2023
Midazolam
Solution for Injection/Infusion
Isoflurane
Inhalation vapour, liquid. Isoflurane delivered by the AnaConDa-S (Anaesthetic Conserving Device)
Hôpital Femme-Mère-Enfant Groupe Hospitalier Est, Lyon
CHU de NANTES, Hôpital Mère-Enfant, Nantes
Hôpital Robert-Debré AP-HP, Paris
Hôpitaux Universitaires Paris Sud Site Bicetre, Paris
Centre Hospitalier Universitaire de Reims, Reims
Hôpitaux Universitaires de Strasbourg Hôpital de Hautepierre, Strasbourg
Universitätsklinikum Köln, Cologne
Universitätsklinik Freiburg, Freiburg im Breisgau
Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg
Universitätsklinikum Jena, Jena
Hospital Materno Infantil Sant Joan de Deu Hospital, Barcelona
Hospital Universitario Reina Sofía, Córdoba
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Infantil Universitario Niño Jesús Pediatric Intensive Care Unit, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Regional Universitario, Carlos Haya, Málaga
Hospital Universitario Virgen del Rocio de Sevilla, Seville
Hospital Universitari i Politecnic La Fe, Valencia
Karolinska Universitetssjukhus Solna, Solna
Leeds Teaching Hospitals NHS Trust, Leeds
University Hospitals of Leicester NHS Trust, Leicester
Imperial College Healthcare NHS Trust, London
Royal Manchester Children's Hospital, Manchester
Lead Sponsor
Sedana Medical
INDUSTRY